ArticleHealth science reports2026
Anaemia Among Women in Lesotho: Findings From 2023 to 2024 Demographic and Health Survey.
Article in Health science reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Anaemia remains a severe public health concern worldwide, with more women of reproductive age being affected, especially in low- and middle-income countries. Anaemia affects an estimated 613.2 million women of reproductive age (15-49 years) globally. The burden is disproportionately concentrated in South Asia and sub-Saharan Africa (SSA), regions that consistently record the highest anaemia prevalence worldwide. The study assessed the prevalence and factors associated with anaemia among reproductive-age women in Lesotho. Methods: This study used cross-sectional data from the 2023-2024 Lesotho Demographic and Health Survey (LDHS) conducted by the Ministry of Health. The analysis included 3,105 women aged 15-49 years with complete haemoglobin measurement. Data were collected from November 27, 2023, to February 29, 2024. Descriptive statistics were used to estimate the prevalence of anaemia. A binary logistic regression model was fitted to identify the factors associated with anaemia, and the results were presented as crude and adjusted odds ratios (AORs) with corresponding 95% confidence intervals (95% CI). Statistical significance was set at Results: The overall prevalence of anaemia among women of reproductive age in Lesotho was 53.7% [95% CI = 51.2-56.2]. The odds of anaemia were significantly highest among those aged 45-49 (AOR = 1.78; 95% CI = 1.17-2.70). Married or cohabiting women had lower odds of anaemia than those never in union (AOR = 0.55; 95% CI = 0.40-0.74). Women who had given birth once had lower odds of anaemia than nulliparous women (AOR = 0.64; 95% CI = 0.46-0.89). Women for whom obtaining money needed for healthcare was not a problem had lower odds of anaemia than those who reported it as a big problem (AOR = 0.73; 95% CI = 0.57-0.93). Women in Quthing (AOR = 0.60; 95% CI = 0.39-0.91) and Qacha's Nek (AOR = 0.61; 95% CI = 0.39-0.95) had lower odds of anaemia than those in Butha-Buthe. Conclusion: Anaemia remains a severe public health problem among women of reproductive age in Lesotho. Age, marital status, parity, financial access to healthcare, and region of residence were associated with anaemia. Public health interventions addressing socioeconomic barriers and improving access to healthcare services may contribute to reducing the burden of anaemia among women in Lesotho.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.